Anne Bergeron, Ph.D. - Publications

Affiliations: 
2005 Universite Laval (Canada) 
Area:
Molecular Biology, Genetics, Pathology

62/234 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Legendre M, Butt A, Borie R, Debray MP, Bouvry D, Filhol-Blin E, Desroziers T, Nau V, Copin B, Dastot-Le Moal F, Héry M, Duquesnoy P, Allou N, Bergeron A, Bermudez J, et al. Functional assessment and phenotypic heterogeneity of and mutations in interstitial lung diseases and lung cancer. The European Respiratory Journal. PMID 32855221 DOI: 10.1183/13993003.02806-2020  0.314
2020 Bondeelle L, Chevret S, Hurabielle C, Samy L, Goletto T, Costantini A, de Fontbrune FS, Michonneau D, Socié G, Tazi A, Bouaziz JD, Bergeron A. Effect of Ruxolitinib on lung function after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32738501 DOI: 10.1016/J.Bbmt.2020.07.033  0.355
2020 Bondeelle L, Chevret S, Hurabielle C, Fontbrune FSD, Michonneau D, Tazi A, Bouaziz JD, Bergeron A. Effet du ruxolitinib sur la fonction respiratoire après allogreffe de cellules souches hématopoiétiques Revue Des Maladies Respiratoires ActualitéS. 12: 249. DOI: 10.1016/J.Rmra.2019.11.558  0.314
2019 Wilhelm B, Milan T, Celton M, Lagacé K, Roques E, Bresson E, Bergeron A, Hebert J, Lamontagne V, Cellot S, Barabé F. THE INTEGRATED USE OF HUMAN MODELS OF LEUKEMIA TO IDENTIFY POTENTIAL THERAPEUTIC TARGETS Experimental Hematology. 76: S92-S93. DOI: 10.1016/J.Exphem.2019.06.460  0.315
2018 Bondeelle L, Bergeron A. Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation. Expert Review of Respiratory Medicine. PMID 30523731 DOI: 10.1080/17476348.2019.1557049  0.339
2018 Fertitta L, Sicre de Fontbrune F, Battistella M, De Masson A, Bergeron A, Ranta D, Vignon-Pennamen MD, Bagot M, Bouaziz JD. Folliculotropic Mycosis fungoides associated with GATA2 deficiency: a new skin manifestation. The British Journal of Dermatology. PMID 30101490 DOI: 10.1111/Bjd.17081  0.32
2018 Meignin V, Thivolet-Bejui F, Kambouchner M, Hussenet C, Bondeelle L, Mitchell A, Chagnon K, Begueret H, Segers V, Cottin V, Tazi A, Chevret S, Danel C, Bergeron A. Lung histopathology of noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Histopathology. PMID 29953629 DOI: 10.1111/His.13697  0.32
2018 Bergeron A, Chevret S, de Latour RP, Chagnon K, de Margerie-Mellon C, Rivière F, Robin M, Mani J, Lorillon G, Socié G, Tazi A. Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation. The European Respiratory Journal. PMID 29650555 DOI: 10.1183/13993003.02617-2017  0.363
2018 Fertitta L, Fontbrune FSd, Battistella M, Masson AD, Bergeron A, Ranta D, Vignon-Pennamen M-, Bagot M, Bouaziz J-. Premier cas de mycosis fongoïde associé à un déficit en GATA2 Annales De Dermatologie Et De Venereologie. 145. DOI: 10.1016/J.Annder.2018.09.423  0.319
2017 Hilmi M, Bally C, Burns R, Lorillon G, Bergeron A, Fenaux P, Ades L. Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine. Annals of Hematology. PMID 29170809 DOI: 10.1007/S00277-017-3190-8  0.319
2017 Bergeron A, Cheng GS. Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation. Clinics in Chest Medicine. 38: 607-621. PMID 29128013 DOI: 10.1016/J.Ccm.2017.07.003  0.362
2017 Brosseau S, Gounant V, Naltet C, Théou-Anton N, Cazes A, Smonig R, Neuville M, Khalil A, Mikail N, Meignin V, Bergeron A, Zalcman G. Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation. Clinical Lung Cancer. PMID 28844392 DOI: 10.1016/J.Cllc.2017.07.003  0.308
2017 Bergeron A, Chevret S, Granata A, Chevallier P, Vincent L, Huynh A, Tabrizi R, Labussiere-Wallet H, Bernard M, Chantepie S, Bay JO, Thiebaut-Bertrand A, Thepot S, Contentin N, Fornecker LM, et al. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial. Jama. 318: 557-566. PMID 28787506 DOI: 10.1001/Jama.2017.9938  0.329
2017 Weatherald J, Chaumais MC, Savale L, Jaïs X, Seferian A, Canuet M, Bouvaist H, Magro P, Bergeron A, Guignabert C, Sitbon O, Simonneau G, Humbert M, Montani D. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study. The European Respiratory Journal. 50. PMID 28751413 DOI: 10.1183/13993003.00217-2017  0.301
2017 Bergeron A. Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation. Clinics in Chest Medicine. 38: 249-262. PMID 28477637 DOI: 10.1016/J.Ccm.2016.12.013  0.363
2017 Hurabielle C, Sicre de Fontbrune F, Moins-Teisserenc H, Robin M, Jachiet M, Coman T, Cassius C, Chasset F, de Masson A, Michonneau D, Bagot M, Bergeron A, Socié G, Peffault de Latour R, Bouaziz JD. Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic Graft-Versus-Host Disease. The British Journal of Dermatology. PMID 28422274 DOI: 10.1111/Bjd.15593  0.309
2017 Lothe-Cartier MN, Bellocq A, Latour RPD, Chevret S, Bergeron A. Allo’Rehab : profil fonctionnel à l’exercice, faisabilité et bénéfices de la réhabilitation respiratoire chez les patients atteints du syndrome de bronchiolite oblitérante postallogreffe de cellules souches hématopoïétiques Revue Des Maladies Respiratoires. 34. DOI: 10.1016/J.Rmr.2016.10.152  0.309
2017 Burbach M, Peraldi M, Bergeron A, Touratier S, Molina JM, Alanio A, Denis B, Bretagne S, Resche-Rigon M. Aspergillose invasive (IA) chez les patients transplantés rénaux : survie et étude monocentrique cas–témoins des facteurs de risque dans un service de transplantation rénale sur la période 2006–2016 Medecine Et Maladies Infectieuses. 47. DOI: 10.1016/J.Medmal.2017.03.196  0.307
2016 Lepelletier C, Bengoufa D, Lyes Z, de Masson A, Chasset F, Jachiet M, Michonneau D, Robin M, Peffault de Latour R, Sicre de Fontbrune F, Tandjaoui-Lambiotte Y, Bensussan A, Rybojad M, Tazi A, Bagot M, ... ... Bergeron A, et al. Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation. Jama Dermatology. PMID 27851860 DOI: 10.1001/Jamadermatol.2016.3976  0.317
2016 Barabé F, Gil L, Celton M, Bergeron A, Lamontagne V, Roques É, Lagacé K, Forest A, Johnson R, Pécheux L, Simard J, Pelloux J, Bellemare-Pelletier A, Gagnon E, Hebert J, et al. Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target. Leukemia. PMID 27780967 DOI: 10.1038/Leu.2016.302  0.309
2016 Chasset F, De Masson A, Le Buanec H, Xhaard A, Sicre de Fontbrune F, Robin M, Rybojad M, Parquet N, Brignier AC, Coman T, Bengoufa D, Bergeron A, Peffault de Latour R, Bagot M, Bensussan A, et al. APRIL levels are associated with disease activity in human chronic graft versus host disease. Haematologica. PMID 26992945 DOI: 10.3324/Haematol.2016.145409  0.312
2016 Burgel PR, Bergeron A, Knoop C, Dusser D. [Small airway diseases and immune deficiency]. Revue Des Maladies Respiratoires. PMID 26854188 DOI: 10.1016/J.Rmr.2015.11.003  0.313
2016 Bergeron A, Chevret S, Peffault De La Tour R, Chagnon K, De Bazelaire C, Rivière F, Robin M, Mani J, Lorillon G, Gérard S, Tazi A. Incidence, Risk Factors and Outcome of Late Onset Noninfectious Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study Blood. 128: 4562-4562. DOI: 10.1182/Blood.V128.22.4562.4562  0.343
2016 Cornetto MA, Chevret S, Abbes S, Mellon CDM, Hussenet C, Fontbrune FSD, Tazi A, Ribaud P, Bergeron A. Scanner thoracique précoce après allogreffe de cellules souches hématopoïétiques Revue Des Maladies Respiratoires. 33. DOI: 10.1016/J.Rmr.2015.10.671  0.306
2016 Haustraete E, Obert J, Diab S, Zini J, Hussenet C, Lerolle N, Tazi A, Bergeron A. Pneumopathies liées à l’idélalisib Revue Des Maladies Respiratoires. 33. DOI: 10.1016/J.Rmr.2015.10.225  0.312
2016 Lepelletier C, Bengoufa D, Lyes Z, Masson Ad, Chasset F, Tazi A, Bagot M, Socié G, Bergeron A, Bouaziz J. 273 Dermato-Pulmonary syndrome associated with anti-melanoma differentiation-associated gene 5 antibodies after allogeneic hematopoietic stem cell transplantation: a monocentric retrospective study Journal of Investigative Dermatology. 136. DOI: 10.1016/J.Jid.2016.06.293  0.317
2016 Lepelletier C, Bengoufa D, Lyes Z, Masson Ad, Chasset F, Jachiet M, Michonneau D, Robin M, Peffault-de-Latour R, Sicre-de-Fontbrune F, Tandjaoui-Lambiotte Y, Bensussan A, Rybojad M, Tazi A, Bagot M, ... ... Bergeron A, et al. Syndrome dermato-pulmonaire avec anticorps anti-MDA5 après allogreffe de cellules souches hématopoïétiques Annales De Dermatologie Et De Venereologie. 143. DOI: 10.1016/J.Annder.2016.09.175  0.325
2015 Hadjadj J, Malphettes M, Fieschi C, Oksenhendler E, Tazi A, Bergeron A. [Lung disease in adult common variable immunodeficiency]. Revue Des Maladies Respiratoires. PMID 26071128 DOI: 10.1016/J.Rmr.2015.05.005  0.321
2015 Bergeron A, Chevret S, Chagnon K, Godet C, Bergot E, Peffault de Latour R, Dominique S, de Revel T, Juvin K, Maillard N, Reman O, Contentin N, Robin M, Buzyn A, Socié G, et al. Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation. American Journal of Respiratory and Critical Care Medicine. 191: 1242-9. PMID 25835160 DOI: 10.1164/Rccm.201410-1818Oc  0.31
2015 Angileri F, Bergeron A, Morrow G, Lettre F, Gray G, Hutchin T, Ball S, Tanguay RM. Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1. Jimd Reports. 19: 43-58. PMID 25681080 DOI: 10.1007/8904_2014_363  0.689
2015 Barabe F, Celton M, Forest A, Bergeron A, Johnson R, Gil L, Bellemare-Pelletier A, Cellot S, Hebert J, Gagnon E, Wilhelm BT. Abstract A2-14: Integrated genetic and epigenetic analysis of model and patient acute myeloid leukemias Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A2-14  0.312
2014 Godet C, Le Goff J, Beby-Defaux A, Robin M, Raffoux E, Arnulf B, Roblot F, Frat JP, Maillard N, Tazi A, Bergeron A. Human metapneumovirus pneumonia in patients with hematological malignancies. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 61: 593-6. PMID 25440914 DOI: 10.1016/J.Jcv.2014.08.019  0.328
2014 Schlemmer F, Chevret S, Lorillon G, De Bazelaire C, Peffault de Latour R, Meignin V, Michallet M, Hermet E, Wyplosz B, Houdouin V, Marchand-Adam S, Socié G, Tazi A, Bergeron A. Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respiratory Medicine. 108: 1525-33. PMID 25260979 DOI: 10.1016/J.Rmed.2014.09.006  0.348
2014 Lerolle N, Raffoux E, Socie G, Touratier S, Sauvageon H, Porcher R, Bretagne S, Bergeron A, Azoulay E, Molina JM, Lafaurie M. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 20: O952-9. PMID 24861577 DOI: 10.1111/1469-0691.12688  0.338
2014 Wolfromm A, Porcher R, Legoff J, Peffault de Latour R, Xhaard A, de Fontbrune FS, Ribaud P, Bergeron A, Socié G, Robin M. Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1238-41. PMID 24732781 DOI: 10.1016/J.Bbmt.2014.04.004  0.33
2013 Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T, Robin M, Ribaud P, Socié G, Tazi A. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transplantation. 48: 819-24. PMID 23208317 DOI: 10.1038/Bmt.2012.241  0.36
2012 Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, Lacroix C, Poirot JL, Bouges C, Derouin F, Tazi A, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 119: 1831-7; quiz 1956. PMID 22010103 DOI: 10.1182/Blood-2011-04-351601  0.354
2012 Schlemmer F, Lorillon G, Bergeron A. Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation | Les complications pulmonaires non infectieuses de l'allogreffe de cellules souches hématopoïétiques Reanimation. 21: S418-S425. DOI: 10.1007/S13546-011-0333-4  0.383
2011 Lorillon G, Robin M, Meignin V, Ribaud P, Lescoeur B, Gossot D, Socié G, Tazi A, Bergeron A. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation. The European Respiratory Journal. 38: 470-2. PMID 21804164 DOI: 10.1183/09031936.00003711  0.367
2011 Lamour C, Bergeron A. Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders. Revue Des Maladies Respiratoires. 28: e18-27. PMID 21742229 DOI: 10.1016/J.Rmr.2009.04.001  0.306
2011 Bergeron A, Bengoufa D, Feuillet S, Meignin V, Peffault de Latour R, Rybojad M, Gossot D, Azoulay E, Socié G, Tazi A. The spectrum of lung involvement in collagen vascular-like diseases following allogeneic hematopoietic stem cell transplantation: report of 6 cases and review of the literature. Medicine. 90: 146-57. PMID 21358437 DOI: 10.1097/Md.0B013E31821160Af  0.331
2011 Borie R, Schneider S, Debray MP, Adle-Biasssette H, Danel C, Bergeron A, Mariette X, Aubier M, Papo T, Crestani B. Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome. Respiratory Medicine. 105: 130-6. PMID 21050739 DOI: 10.1016/J.Rmed.2010.07.017  0.325
2011 Wolfromm A, Porcher R, Legoff J, Latour RPd, Xhaard A, Ribaud P, Scieux C, Bergeron A, Socie G, Robin M. Viral Respiratory Infections After Allogeneic Hemaotpoietic Stem Cell Transplantation: Outcome and Prognosis Blood. 118: 491-491. DOI: 10.1182/Blood.V118.21.491.491  0.339
2010 Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Lacroix C, Raffoux E, Isnard F, Poirot J, Vekhoff A, Bouges-Michel C, Tazi A, Ribaud P. Mycological Diagnosis of Invasive Pulmonary Aspergillosis Should Depend on Both the Underlying Condition and the Neutropenia Status of Patients with Hematologic Malignancies Blood. 116: 1243-1243. DOI: 10.1182/Blood.V116.21.1243.1243  0.307
2009 Bergeron A, Chagnon K, Feuillet S, Chevret S, Tazi A. [Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation]. Revue Des Maladies Respiratoires. 26: 794-800. PMID 19953024 DOI: 10.1016/S0761-8425(09)72433-7  0.329
2009 Lamour C, Bergeron A. [Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders]. Revue Des Maladies Respiratoires. 26: 655-65. PMID 19623109 DOI: 10.1016/S0761-8425(09)74695-9  0.313
2009 Mourez T, Bergeron A, Ribaud P, Scieux C, de Latour RP, Tazi A, Socié G, Simon F, LeGoff J. Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerging Infectious Diseases. 15: 107-9. PMID 19116066 DOI: 10.3201/1501.080758  0.345
2008 Orejuela D, Jorquera R, Bergeron A, Finegold MJ, Tanguay RM. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model. Journal of Hepatology. 48: 308-17. PMID 18093685 DOI: 10.1016/J.Jhep.2007.09.014  0.513
2008 Langlois C, Jorquera R, Orejuela D, Bergeron A, Finegold MJ, Rhead WJ, Tanguay RM. Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monoethylester and vitamin C treatment Molecular Genetics and Metabolism. 93: 306-313. PMID 18023223 DOI: 10.1016/J.Ymgme.2007.09.018  0.506
2007 Madureira A, Bergeron A, Lacroix C, Robin M, Rocha V, de Latour RP, Ferry C, Devergie A, Lapalu J, Gluckmana E, Socié G, Ghannoum M, Ribaud P. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. International Journal of Antimicrobial Agents. 30: 551-4. PMID 18029149 DOI: 10.1016/J.Ijantimicag.2007.07.026  0.334
2007 de Fontbrune FS, Robin M, Porcher R, Scieux C, de Latour RP, Ferry C, Rocha V, Boudjedir K, Devergie A, Bergeron A, Gluckman E, Azoulay E, Lapalu J, Socié G, Ribaud P. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 1019-24. PMID 17879919 DOI: 10.1086/521912  0.324
2007 Robin M, Marque-Juillet S, Scieux C, Peffault de Latour R, Ferry C, Rocha V, Molina JM, Bergeron A, Devergie A, Gluckman E, Ribaud P, Socié G. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica. 92: 1254-7. PMID 17666361 DOI: 10.3324/Haematol.11279  0.313
2007 Bergeron A, Réa D, Levy V, Picard C, Meignin V, Tamburini J, Bruzzoni-Giovanelli H, Calvo F, Tazi A, Rousselot P. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. American Journal of Respiratory and Critical Care Medicine. 176: 814-8. PMID 17600277 DOI: 10.1164/Rccm.200705-715Cr  0.317
2007 Bergeron A, Belle A, Chevret S, Ribaud P, Devergie A, Esperou H, Ades L, Gluckman E, Socié G, Tazi A. Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplantation. 39: 547-53. PMID 17351647 DOI: 10.1038/Sj.Bmt.1705637  0.371
2006 Bergeron A, Jorquera R, Orejuela D, Tanguay RM. Involvement of endoplasmic reticulum stress in hereditary tyrosinemia type I. The Journal of Biological Chemistry. 281: 5329-34. PMID 16317004 DOI: 10.1074/Jbc.M506804200  0.521
2005 Pavie J, Lacroix C, Hermoso DG, Robin M, Ferry C, Bergeron A, Feuilhade M, Dromer F, Gluckman E, Molina JM, Ribaud P. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. Journal of Clinical Microbiology. 43: 4902-4. PMID 16145172 DOI: 10.1128/Jcm.43.9.4902-4904.2005  0.309
2005 Dreumont N, Maresca A, Boisclair-Lachance JF, Bergeron A, Tanguay RM. A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay. Bmc Molecular Biology. 6: 1. PMID 15638932 DOI: 10.1186/1471-2199-6-1  0.473
2004 Bergeron A, Lettre F, Russo P, Morissette J, Tanguay RM. No evidence of maternal cell colonization in reverted liver nodules of tyrosinemia type I patients. Gastroenterology. 127: 1381-5. PMID 15521007 DOI: 10.1053/J.Gastro.2004.08.013  0.544
2003 Bergeron A, Jorquera R, Tanguay RM. [Hereditary tyrosinemia: an endoplasmic reticulum stress disorder?]. MéDecine Sciences : M/S. 19: 976-80. PMID 14613010 DOI: 10.1051/Medsci/20031910976  0.513
2001 Dreumont N, Poudrier JA, Bergeron A, Levy HL, Baklouti F, Tanguay RM. A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation. Bmc Genetics. 2: 9. PMID 11476670 DOI: 10.1186/1471-2156-2-9  0.517
2001 Bergeron A, D'Astous M, Timm DE, Tanguay RM. Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1. The Journal of Biological Chemistry. 276: 15225-31. PMID 11278491 DOI: 10.1074/jbc.M009341200  0.467
1998 Tazi A, Montcelly L, Bergeron A, Valeyre D, Battesti J, Hance AJ. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. American Journal of Respiratory and Critical Care Medicine. 157: 2007-2010. PMID 9620939 DOI: 10.1164/Ajrccm.157.6.9709026  0.314
Low-probability matches (unlikely to be authored by this person)
2019 Milan T, Celton M, Lagacé K, Roques E, Bergeron A, Barabé F, Wilhelm B. INTEGRATIVE EPIGENOMIC ANALYSIS TO IDENTIFY POTENTIAL BIOMARKERS IN KMT2A TRANSLOCATED ACUTE MYELOID LEUKEMIA Experimental Hematology. 76: S77-S78. DOI: 10.1016/J.Exphem.2019.06.405  0.3
2019 Cheng GS, Bondeelle L, Gooley T, He Q, Jamani K, Krakow EF, Flowers MED, de Latour RP, Michonneau D, Socié G, Chien JW, Chevret S, Bergeron A. Azithromycin use and increased cancer risk among patients with bronchiolitis obliterans after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31682980 DOI: 10.1016/J.Bbmt.2019.10.025  0.3
2012 Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A, Cottin V, Jeanfaivre T, Godet C, Pineau M, Germaud P. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 31: 3231-9. PMID 22782438 DOI: 10.1007/S10096-012-1690-Y  0.3
2018 Xhaard A, Porcher R, Bergeron A, Alanio A, Touratier S, Bretagne S, de Margerie-Mellon C, Sicre de Fontbrune F, Itzykson R, Coman T, Robin M, Cabannes-Hamy A, Socié G, Peffault de Latour R. Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study. Annals of Hematology. PMID 30353389 DOI: 10.1007/S00277-018-3530-3  0.299
2019 Garg S, Reyes-Palomares A, He L, Bergeron A, Lavallée VP, Lemieux S, Gendron P, Rohde C, Xia J, Jagdhane P, Müller-Tidow C, Lipka DB, Imren S, Humphries RK, Waskow C, et al. Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML. Blood. PMID 31076446 DOI: 10.1182/Blood.2018862383  0.299
2020 Weatherald J, Bondeelle L, Chaumais MC, Guignabert C, Savale L, Jaïs X, Sitbon O, Rousselot P, Humbert M, Bergeron A, Montani D. Pulmonary Complications of Bcr-Abl Tyrosine Kinase Inhibitors. The European Respiratory Journal. PMID 32527740 DOI: 10.1183/13993003.00279-2020  0.298
1996 Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, Hervé P, Raffestin B, Simonneau G. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension RéAnimation Urgences. 5: 69. DOI: 10.1016/S1164-6756(96)80065-X  0.298
2018 Levi L, Groh M, Castro ND, Bergeron A, Schlemmer F. BCGites après immunothérapie pour cancer de vessie, une pathologie hétérogène: physiopathologie, description clinique, prise en charge diagnostique et thérapeutique Revue Des Maladies Respiratoires. 35: 416-429. PMID 29754838 DOI: 10.1016/J.Rmr.2017.11.010  0.297
2009 Miranda Sd, Bergeron A, Meignin V. Un boulanger dans le pétrin Revue Des Maladies Respiratoires ActualitéS. 1: 133-134. DOI: 10.1016/S1877-1203(09)72453-X  0.297
2013 Burgel PR, Bergeron A, de Blic J, Bonniaud P, Bourdin A, Chanez P, Chinet T, Dalphin JC, Devillier P, Deschildre A, Didier A, Kambouchner M, Knoop C, Laurent F, Nunes H, et al. Small airways diseases, excluding asthma and COPD: an overview. European Respiratory Review : An Official Journal of the European Respiratory Society. 22: 131-47. PMID 23728867 DOI: 10.1183/09059180.00001313  0.296
2011 Berthiaume S, Kennedy JA, Bergeron A, Belanger M, Dick JE, Barabe F. Comparing Human Fetal Liver, Cord Blood and Adult Bone Marrow Stem/Progenitor Hematopoietic Cells As Cells of Origin of Human MLL Leukemias Blood. 118: 2956-2956. DOI: 10.1182/Blood.V118.21.2956.2956  0.295
2019 Chemaly RF, Dadwal SS, Bergeron A, Ljungman P, Kim YJ, Cheng GS, Pipavath SN, Limaye AP, Blanchard E, Winston DJ, Stiff PJ, Zuckerman T, Lachance S, Rahav G, Small CB, et al. A phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31793991 DOI: 10.1093/Cid/Ciz1166  0.294
2013 Tardieu M, Rybojad M, Peffault de Latour R, Robin M, de Masson A, Xhaard A, Le Buanec H, Parquet N, Sicre de Fontbrune F, Bergeron A, Scieux C, Dessirier V, Bensussan A, Bagot M, Socié G, et al. Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation. Blood. 122: 463-5. PMID 23869081 DOI: 10.1182/Blood-2013-03-488148  0.294
2012 Salmeron G, Porcher R, Bergeron A, Robin M, Peffault de Latour R, Ferry C, Rocha V, Petropoulou A, Xhaard A, Lacroix C, Sulahian A, Socié G, Ribaud P. Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis. Haematologica. 97: 1357-63. PMID 22371177 DOI: 10.3324/Haematol.2011.058255  0.293
2019 Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, Bergeron A, Shoham S, Ljungman P, Waghmare A, Blanchard E, Kim YJ, McKevitt M, Porter DP, Jordan R, et al. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31915807 DOI: 10.1093/Cid/Ciz1167  0.293
2017 Bergeron A, Bondeelle L, Chevret S. Azithromycin and Survival After Hematopoietic Stem Cell Transplant-Reply. Jama. 318: 2492. PMID 29279924 DOI: 10.1001/Jama.2017.17236  0.293
2016 Chasset F, Masson AD, Le-Buanec H, Xhaa A, Fontbrune FSd, Robin M, Rybojad M, Parquet N, Brignier A, Coman T, Bengoufa D, Bergeron A, Latour RPd, Bagot M, Bensussan A, et al. Les taux d’APRIL sont associés à l’activité de la réaction chronique du greffon contre l’hôte chez l’homme Annales De Dermatologie Et De Venereologie. 143. DOI: 10.1016/J.Annder.2016.09.061  0.292
2017 Denis B, Ronchetti AM, Resche-Rigon M, Bergeron A, Raffoux E, Touratier S, Alanio A. Épidémiologie, diagnostic et évolution de 45 cas de mucormycose invasive sur la période 2006–2016 dans un hôpital universitaire Medecine Et Maladies Infectieuses. 47. DOI: 10.1016/J.Medmal.2017.03.025  0.292
2015 Patout M, Fercocq C, Alanio A, Touratier S, Raffoux E, Derouin F, Molina J, Bretagne S, Ribaud P, Bergeron A. Aspergilloses pulmonaires invasives survenant sous traitement par posaconazole (PZA) Revue Des Maladies Respiratoires. 32: A169. DOI: 10.1016/J.Rmr.2014.10.169  0.292
2019 Bondeelle L, Gras J, Michonneau D, Houdouin V, Hermet E, Blin N, Nicolini F, Michallet M, Dominique S, Huynh A, Leroy S, Socié G, Thabut G, Reynaud-Gaubert M, Tazi A, ... Bergeron A, et al. Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 31413312 DOI: 10.1038/S41409-019-0636-8  0.292
2016 Godet C, Laurent F, Beraud G, Toper C, Camara B, Philippe B, Germaud P, Cottin V, Roblot F, Bergeron A, Cadranel J, Beigelman-Aubry C. Phénotypage des aspergilloses pulmonaires chroniques Revue Des Maladies Respiratoires. 33. DOI: 10.1016/J.Rmr.2015.10.011  0.291
2011 Girard P, Bergeron A, Soulié M. [Management of side effects of targeted therapies in renal cancer: pulmonary side effects]. Bulletin Du Cancer. 98: S95-S115. PMID 25819131 DOI: 10.1684/Bdc.2011.1446  0.291
2008 Bergeron A, Feuillet S, Meignin V, Socie G, Tazi A. Les complications pulmonaires tardives non infectieuses après allogreffe de cellules souches hématopoïétiques Revue Des Maladies Respiratoires. 25: 173-183. PMID 18449079 DOI: 10.1016/S0761-8425(08)71515-8  0.29
2017 Godet C, Couturaud F, Ragot S, Laurent F, Brun AL, Bergeron A, Cadranel J, Nebulamb g. Aspergillose bronchopulmonaire allergique : évaluation d’un traitement d’entretien par Ambisome® nébulisé Revue Des Maladies Respiratoires. 34: 581-587. PMID 28552257 DOI: 10.1016/J.Rmr.2017.04.001  0.288
2008 Cony-Makhoul P, Bergeron A, Corm S, Dubruille V, Rea D, Rigal-Huguet F, Nicolini FE. [Guidelines for the management of dasatinib (Sprycel)-induced side effects in chronic myelogenous leukemia and Philadelphia positive acute lymphoblastic leukemias]. Bulletin Du Cancer. 95: 805-11. PMID 18829412 DOI: 10.1684/Bdc.2008.0703  0.287
2009 Bergeron A, Miranda Sd, Meignin V. Une histoire sans fin Revue Des Maladies Respiratoires ActualitéS. 1: 137-138. DOI: 10.1016/S1877-1203(09)72455-3  0.287
2014 Hussenet C, Meignin V, Béjui-Thivolet F, Kambouchner M, Danel C, Bergeron A. Démembrement histopathologique des complications pulmonaires non infectieuses survenant après allogreffe de cellules souches hématopoïétiques et corrélation clinique Revue Des Maladies Respiratoires. 31. DOI: 10.1016/J.Rmr.2013.10.129  0.287
2011 Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, Molina JM, Derouin F, Menotti J. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 17: 1531-7. PMID 20946413 DOI: 10.1111/J.1469-0691.2010.03400.X  0.285
2010 Uzunhan Y, Cadranel J, Boissel N, Gardin C, Arnulf B, Bergeron A. [The specific pulmonary manifestations of acute myeloid leukaemia]. Revue Des Maladies Respiratoires. 27: 589-98. PMID 20610074 DOI: 10.1016/J.Rmr.2010.05.001  0.284
2007 Bollée G, Sarfati C, Thiéry G, Bergeron A, de Miranda S, Menotti J, de Castro N, Tazi A, Schlemmer B, Azoulay E. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest. 132: 1305-10. PMID 17934116 DOI: 10.1378/Chest.07-0223  0.284
2016 Godet C, Laurent F, Bergeron A, Ingrand P, Beigelman-Aubry C, Camara B, Cottin V, Germaud P, Philippe B, Pison C, Toper C, Carette MF, Frat JP, Béraud G, Roblot F, et al. Computed Tomography Assessment of Response to Treatment in Chronic Pulmonary Aspergillosis. Chest. PMID 26905365 DOI: 10.1016/j.chest.2016.02.640  0.283
2000 Soler P, Bergeron A, Kambouchner M, Groussard O, Brauner M, Grenier P, Crestani B, Mal H, Tazi A, Battesti JP, Loiseau P, Valeyre D. Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? American Journal of Respiratory and Critical Care Medicine. 162: 264-70. PMID 10903252 DOI: 10.1164/Ajrccm.162.1.9906010  0.282
2010 Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, Raffoux E, Arnulf B, Socié G, Ribaud P, Tazi A. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest. 137: 410-5. PMID 19801584 DOI: 10.1378/Chest.09-0701  0.282
2012 Lorillon G, Bergeron A, Detourmignies L, Jouneau S, Wallaert B, Frija J, Tazi A. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. American Journal of Respiratory and Critical Care Medicine. 186: 930-2. PMID 23118088 DOI: 10.1164/Ajrccm.186.9.930  0.281
2006 Teira P, Agbalika F, Bergeron A, Bernaudin F, Carmagnat M, Peffault de Latour R, Rocha V, Devergie A, Rabian C, Gluckman E, Ribaud P, Socié G, Robin M. Primary Epstein-Barr virus infection with pneumonia transmitted by allogeneic bone marrow after transplantation. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: 892-5. PMID 16941371 DOI: 10.1086/507034  0.28
2004 Azoulay E, Thiéry G, Chevret S, Moreau D, Darmon M, Bergeron A, Yang K, Meignin V, Ciroldi M, Le Gall JR, Tazi A, Schlemmer B. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine. 83: 360-70. PMID 15525848 DOI: 10.1097/01.Md.0000145370.63676.Fb  0.28
2012 Feuillet S, Lorillon G, Bergeron A, Meignin V, Hachulla E, Mekinian A, Gottenberg J, Mariette X, Tazi A. Évaluation de l’efficacité et de la tolérance du rituximab dans les pneumopathies infiltrantes diffuses associées au syndrome de Gougerot-Sjögren primitif à partir d’une série de cinq cas Revue Des Maladies Respiratoires. 29: A22-A23. DOI: 10.1016/J.Rmr.2011.10.022  0.28
2007 Camuset J, Nunes H, Dombret MC, Bergeron A, Henno P, Philippe B, Dauriat G, Mangiapan G, Rabbat A, Cadranel J. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest. 131: 1435-41. PMID 17400661 DOI: 10.1378/Chest.06-2441  0.279
2012 Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, Cornet M, Isnard F, Raffoux E, Brethon B, Lacroix C, Touratier S, Latgé JP, Bouges-Michel C, Tazi A, et al. Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. Journal of Clinical Microbiology. 50: 823-30. PMID 22170907 DOI: 10.1128/Jcm.00750-11  0.279
2016 Pabst C, Bergeron A, Lavallée VP, Yeh J, Gendron P, Norddahl GL, Krosl J, Boivin I, Deneault E, Simard J, Imren S, Boucher G, Eppert K, Herold T, Bohlander SK, et al. GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo. Blood. PMID 26834243 DOI: 10.1182/Blood-2015-11-683649  0.278
2017 Jutant EM, Meignin V, Montani D, Tazi A, Rousselot P, Bergeron A. Bosutinib-related pneumonitis. The European Respiratory Journal. 50. PMID 28899936 DOI: 10.1183/13993003.00930-2017  0.278
2019 Bondeelle L, Bergeron A, Wolff M. Place des nouveaux antibiotiques dans le traitement de la pneumonie aiguë communautaire de l’adulte Revue Des Maladies Respiratoires. 36: 104-117. PMID 30638789 DOI: 10.1016/J.Rmr.2018.04.010  0.277
2019 Maschmeyer G, De Greef J, Mellinghoff SC, Nosari A, Thiebaut-Bertrand A, Bergeron A, Franquet T, Blijlevens NMA, Maertens JA. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia. PMID 30700842 DOI: 10.1038/S41375-019-0388-X  0.276
2015 Gits-Muselli M, Peraldi MN, de Castro N, Delcey V, Menotti J, Guigue N, Hamane S, Raffoux E, Bergeron A, Valade S, Molina JM, Bretagne S, Alanio A. New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards. Plos One. 10: e0125763. PMID 25933203 DOI: 10.1371/Journal.Pone.0125763  0.275
2012 Rivière F, Lorillon G, Meignin V, Desseaux K, Feuillet S, Pavec JL, Tazi A, Bergeron A. Apport de la cytologie du lavage broncho alvéolaire pour le diagnostic d’une pneumopathie en hématologie Revue Des Maladies Respiratoires. 29. DOI: 10.1016/J.Rmr.2011.10.074  0.275
2009 Valin N, De Castro N, Garrait V, Bergeron A, Bouche C, Molina JM. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature. Journal of the International Association of Physicians in Aids Care (Chicago, Ill. : 2002). 8: 113-21. PMID 19270151 DOI: 10.1177/1545109709332019  0.275
2010 Bergeron A. [The lung in haematology diseases: end of a series, the adventure continues]. Revue Des Maladies Respiratoires. 27: 552-3. PMID 20610070 DOI: 10.1016/J.Rmr.2010.04.011  0.275
2015 Chasset F, Buanec HL, Fontbrune FSd, Masson Ad, Rivet J, Bergeron A, Frumholtz L, Schiavon V, Robin M, Rybojad M, Roux J, Tazi A, Latour RPd, Bagot M, Socié G, et al. Présence de populations lymphocytaires Th1, Th17 et Tc17 dans la réaction du greffon contre l’hôte chronique (GVHc) psoriasiforme Annales De Dermatologie Et De Venereologie. 142: 294-294. DOI: 10.1016/J.Annder.2015.04.056  0.275
2013 Deneault E, Wilhelm BT, Bergeron A, Barabé F, Sauvageau G. Identification of non-cell-autonomous networks from engineered feeder cells that enhance murine hematopoietic stem cell activity. Experimental Hematology. 41: 470-478.e4. PMID 23340137 DOI: 10.1016/J.Exphem.2013.01.003  0.275
1995 Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, Herve P, Raffestin B, Simonneau G. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. American Journal of Respiratory and Critical Care Medicine. 151: 384-389. PMID 7842196 DOI: 10.1164/Ajrccm.151.2.7842196  0.275
2020 Talvard-Balland N, Sutra Del Galy A, Michonneau D, Le Buanec H, Chasset F, Robin M, Peffault de Latour R, Xhaard A, Sicre de Fontbrune F, Parquet N, Duchez S, Schiavon V, Rybojad M, Bergeron A, Bagot M, et al. Expansion of circulating CD49b+LAG3+ type 1 regulatory T (Tr1) cells in human chronic graft-versus-host disease. The Journal of Investigative Dermatology. PMID 32428542 DOI: 10.1016/J.Jid.2020.04.018  0.273
2016 Michallet M, Sobh M, Deloire A, Raffoux E, Botton Sd, Caillot D, Reman O, Girault S, Berthon C, Huguet F, Lepretre S, Leguay T, Castaigne S, Royer B, Pautas C, ... ... Bergeron A, et al. Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy. Prospective Observational Study from the Acute Leukemia French Association (ALFA) Group Blood. 128: 3696-3696. DOI: 10.1182/Blood.V128.22.3696.3696  0.271
2014 Rivière F, Chevret S, Schlemmer F, Parquet N, Bouaziz J-, Socié G, Tazi A, Bergeron A. Effet de la photophérèse extracorporelle sur la fonction respiratoire des receveurs d’une allogreffe de cellules souches hématopoïétiques Revue Des Maladies Respiratoires. 31. DOI: 10.1016/J.Rmr.2013.10.247  0.268
2014 Bordeleau ME, Aucagne R, Chagraoui J, Girard S, Mayotte N, Bonneil E, Thibault P, Pabst C, Bergeron A, Barabé F, Hébert J, Sauvageau M, Boutonnet C, Meloche S, Sauvageau G. UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity. Blood. 124: 2362-9. PMID 25185265 DOI: 10.1182/Blood-2014-01-548651  0.267
2010 Salmeron G, Porcher R, Bergeron A, Robin M, Latour RPd, Rocha V, Petropoulou AD, Xhaard A, Sulahian A, Socié G, Ribaud P. Major Improvement of Invasive Aspergillosis Outcome Is Not Enough to Improve Overall Survival In Allogeneic Hematopoietic Stem Cell Transplant Recipients: Results From a Single-Center Retrospective Analysis Blood. 116: 1244-1244. DOI: 10.1182/Blood.V116.21.1244.1244  0.265
2012 Montani D, Bergot E, Günther S, Savale L, Bergeron A, Bourdin A, Bouvaist H, Canuet M, Pison C, Macro M, Poubeau P, Girerd B, Natali D, Guignabert C, Perros F, et al. Pulmonary arterial hypertension in patients treated by dasatinib. Circulation. 125: 2128-37. PMID 22451584 DOI: 10.1161/Circulationaha.111.079921  0.264
2019 Levi LI, Schlemmer F, Castro Nd, Brun O, Veziris N, Argemi X, Roupret M, Launay O, Bergeron A, Groh M. Bacillus Calmette-Guerin infection following intravesical instillation: Does the strain matter? Medecine Et Maladies Infectieuses. 49: 350-355. PMID 30583869 DOI: 10.1016/J.Medmal.2018.11.014  0.264
2010 Uzunhan Y, Cadranel J, Boissel N, Gardin C, Arnulf B, Bergeron A. [Lung involvement in lymphoid and lympho-plasmocytic proliferations (except lymphomas)]. Revue Des Maladies Respiratoires. 27: 599-610. PMID 20610075 DOI: 10.1016/J.Rmr.2010.05.002  0.264
2006 Bergeron A, Hage FE, Kambouchner M, Lecossier D, Tazi A. Characterisation of dendritic cell subsets in lung cancer micro-environments European Respiratory Journal. 28: 1170-1177. PMID 16899480 DOI: 10.1183/09031936.06.00114205  0.263
2011 Lerolle N, Lafaurie M, Touratier S, Tournoud M, Raffoux E, Ribaud P, Lacroix C, Bergeron A, Azoulay E, Molina J. Breakthrough Invasive Fungal Infections (IFI) in patients treated with posaconazole as primary prophylaxis: a four year study F1000research. 2. DOI: 10.7490/F1000Research.1089356.1  0.263
2019 Rech JS, Arnulf B, de Margerie-Mellon C, Talbot A, Malphettes M, Vignon M, Royer B, Lavergne D, Kambouchner M, Meignin V, Bergeron A, Prevot G, Brillet PY, Martinod E, Bridoux F, et al. Lower respiratory tract amyloidosis: presentation, survival and prognostic factors. A multicenter consecutive case series. American Journal of Hematology. PMID 31396978 DOI: 10.1002/Ajh.25608  0.262
2017 Eschapasse E, Hussenet C, Bergeron A, Lebeaux D. [Respiratory infections caused by slow-growing bacteria: Nocardia, Actinomyces, Rhodococcus]. Revue Des Maladies Respiratoires. PMID 28688759 DOI: 10.1016/J.Rmr.2017.02.004  0.262
2015 de Masson A, Bouaziz JD, Le Buanec H, Robin M, O'Meara A, Parquet N, Rybojad M, Hau E, Monfort JB, Branchtein M, Michonneau D, Dessirier V, Sicre de Fontbrune F, Bergeron A, Itzykson R, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 125: 1830-9. PMID 25605369 DOI: 10.1182/Blood-2014-09-599159  0.258
2014 Sulahian A, Porcher R, Bergeron A, Touratier S, Raffoux E, Menotti J, Derouin F, Ribaud P. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis. Journal of Clinical Microbiology. 52: 2328-33. PMID 24740084 DOI: 10.1128/Jcm.03567-13  0.258
2016 Haustraete E, Obert J, Diab S, Abbes S, Zini JM, Valade S, Lerolle N, Albin N, Arnulf B, Bouaziz JD, Hussenet C, Tazi A, Bergeron A. Idelalisib-related pneumonitis. The European Respiratory Journal. PMID 26917607 DOI: 10.1183/13993003.01670-2015  0.255
2012 Saussine A, Tazi A, Feuillet S, Rybojad M, Juillard C, Bergeron A, Dessirier V, Bouhidel F, Janin A, Bensussan A, Bagot M, Bouaziz JD. Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. Plos One. 7: e43588. PMID 22927996 DOI: 10.1371/Journal.Pone.0043588  0.255
2015 Chasset F, Le Buanec H, Sicre de Fontbrune F, de Masson A, Rivet J, Bergeron A, Bagot M, Socié G, Bensussan A, Bouaziz JD. Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host disease. Experimental Dermatology. PMID 26343416 DOI: 10.1111/Exd.12857  0.255
2019 Michallet M, Sobh M, Morisset S, Deloire A, Raffoux E, Botton SD, Caillot D, Chantepie S, Girault S, Berthon C, Bertoli S, Lepretre S, Leguay T, Castaigne S, Marolleau J, ... ... Bergeron A, et al. Acute Myeloid Leukemia and Antifungal Prophylaxis Era: Compliance of AML Centers, Invasive Fungal Infection (IFI) Classification, IFI Incidence and AML Outcomes from ALFA 2007- 02 Study Blood. 134: 2618-2618. DOI: 10.1182/Blood-2019-130642  0.254
2009 Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest. 135: 655-61. PMID 19265086 DOI: 10.1378/Chest.08-1309  0.254
2022 Archer G, Berger I, Bondeelle L, de Margerie-Mellon C, Cassonnet S, de Latour RP, Michonneau D, Chevret S, Bergeron A. Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease? Bone Marrow Transplantation. PMID 36309588 DOI: 10.1038/s41409-022-01859-4  0.253
2009 Chagnon K, Boissel N, Raffoux E, Dombret H, Tazi A, Bergeron A. A new pattern of cytosine-arabinoside-induced lung toxicity. British Journal of Haematology. 147: 771-4. PMID 19735260 DOI: 10.1111/J.1365-2141.2009.07895.X  0.251
2006 Marc K, Bergeron A, Ioos V, Mariette X, Tazi A. Hypertension artérielle pulmonaire au cours d’un syndrome de Sjogren primitif : efficacité du Bosentan Revue Des Maladies Respiratoires. 23: 101. DOI: 10.1016/S0761-8425(06)72383-X  0.249
2006 Louis L, Bergeron A, Galicier L, Oksenhendler E, Tazi A. Bronchiolite oblitérante et maladie de Castleman Revue Des Maladies Respiratoires. 23: 97. DOI: 10.1016/S0761-8425(06)72367-1  0.248
2016 Alanio A, Denis B, Hamane S, Raffoux E, Peffault de Latour R, Menotti J, Amorim S, Touratier S, Bergeron A, Bretagne S. Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis. Emerging Infectious Diseases. 22: 157-8. PMID 26690934 DOI: 10.3201/Eid2201.150848  0.247
2014 Hussenet C, Porcher R, Bazelaire CD, Raffoux E, Sulahian A, Ribaud P, Tazi A, Bergeron A. Suivi séquentiel des anomalies tomodensitométriques de l’aspergillose pulmonaire invasive Revue Des Maladies Respiratoires. 31. DOI: 10.1016/J.Rmr.2013.10.502  0.246
2014 Hussenet C, LeGoff J, Lorillon G, Simon F, Bergeron A. Actinomyces naeslundii lung infection diagnosed by polymerase chain reaction coupled with electrospray-ionization mass spectrometry. Annals of the American Thoracic Society. 11: 1163-5. PMID 25238000 DOI: 10.1513/Annalsats.201405-219Le  0.242
2017 Alanio A, Menotti J, Gits-Muselli M, Hamane S, Denis B, Rafoux E, Peffault de la Tour R, Touratier S, Bergeron A, Guigue N, Bretagne S. Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum. Frontiers in Microbiology. 8: 2040. PMID 29163378 DOI: 10.3389/Fmicb.2017.02040  0.238
2015 Pabst C, Bergeron A, Lavallée V, Yeh J, Gendron P, Krosl J, Boucher G, Lemieux S, Hébert J, Sauvageau G, Barabé F. The Novel Leukemia Stem Cell Marker GPR56 Discriminates Leukemic Subclones with Divergent Stem Cell Properties in Human Acute Myeloid Leukemia Blood. 126: 1859-1859. DOI: 10.1182/Blood.V126.23.1859.1859  0.237
2024 Bos S, Murray J, Marchetti M, Cheng GS, Bergeron A, Wolff D, Sander C, Sharma A, Badawy SM, Peric Z, Piekarska A, Pidala J, Raj K, Penack O, Kulkarni S, et al. ERS/EBMT clinical practice guideline on treatment of pulmonary chronic graft--host disease in adults. The European Respiratory Journal. PMID 38485149 DOI: 10.1183/13993003.01727-2023  0.235
2016 Papo M, Crockett F, Gounant V, Assouad J, Schlemmer F, Bergeron A, Antoine M, Naccache JM. Cystic Pulmonary Myxoid Liposarcoma Mimicking Endobronchial Blood Clot. Journal of Bronchology & Interventional Pulmonology. 23: 152-154. PMID 27058719 DOI: 10.1097/Lbr.0000000000000188  0.235
2020 Peffault de Latour R, Bergeron A, Lengline E, Dupont T, Marchal A, Galicier L, de Castro N, Bondeelle L, Darmon M, Dupin C, Dumas G, Leguen P, Madelaine I, Chevret S, Molina JM, et al. Complement C5 inhibition in patients with COVID-19 - a promising target? Haematologica. PMID 32703791 DOI: 10.3324/Haematol.2020.260117  0.231
2012 Montani D, Bergot E, Günther S, Savale L, Bergeron A, Bourdin A, Bouvaist H, Canuet M, Pison C, Macro M, Poubeau P, Natali D, Guignabert C, Perros F, O’callaghan D-, et al. Hypertension artérielle pulmonaire induite par le dasatinib (dual Src/Abl kinase inhibitor) Revue Des Maladies Respiratoires. 29. DOI: 10.1016/J.Rmr.2011.10.072  0.231
2015 Godet C, Laurent F, Béraud G, Toper C, Camara B, Philippe B, Germaud P, Cottin V, Beigelman-Aubry C, Khalil A, Blouin P, Pouriel M, Roblot F, Bergeron A, Cadranel J, et al. Phenotyping chronic pulmonary aspergillosis by cluster analysis. The European Respiratory Journal. 46: 1509-12. PMID 26381520 DOI: 10.1183/13993003.00869-2015  0.229
2020 Gazaignes S, Bergeron A, Menotti J, Desseaux K, Molina JM, De Castro N. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?] Revue Des Maladies Respiratoires. PMID 32273116 DOI: 10.1016/J.Rmr.2019.12.006  0.228
2023 Bondeelle L, Giannotti F, Chalandon Y, Le Goff J, Tapparel C, Bergeron A. Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 36972802 DOI: 10.1016/j.ajt.2023.03.015  0.227
2021 Lefeuvre C, Salmona M, Bondeelle L, Houdouin V, Feghoul L, Jacquier H, Mercier-Delarue S, Bergeron A, LeGoff J. Frequent lower respiratory tract disease in hematological patients with Parainfluenza virus type 3 infection. Journal of Medical Virology. PMID 34324206 DOI: 10.1002/jmv.27243  0.219
2016 Alanio A, Denis B, Hamane S, Raffoux E, Peffault de la Tour R, Touratier S, Bergeron A, Bretagne S. New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined? The Journal of Antimicrobial Chemotherapy. 71: 2075-8. PMID 27494830 DOI: 10.1093/Jac/Dkw036  0.217
2012 Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L, Lacroix C, Herbrecht R, Legrand F, Mohty M, Michallet M, Cordonnier C, Malak S, Guyotat D, Couderc LJ, et al. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 18: E396-400. PMID 22672535 DOI: 10.1111/j.1469-0691.2012.03908.x  0.215
2022 Glanville AR, Benden C, Bergeron A, Cheng GS, Gottlieb J, Lease ED, Perch M, Todd JL, Williams KM, Verleden GM. Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions. Erj Open Research. 8. PMID 35898810 DOI: 10.1183/23120541.00185-2022  0.214
2017 Tourte M, Lheure C, Gras J, Battistella M, Simon I, Hussenet C, Jachiet M, Bagot M, Tazi A, Bergeron A, Bouaziz JD. Koebner Phenomenon in Eosinophilic Granulomatosis with Polyangiitis (Churg-Srauss). Acta Dermato-Venereologica. PMID 28421235 DOI: 10.2340/00015555-2683  0.214
2009 Feuillet S, Meignin V, Brière J, Brice P, Rocha V, Socié G, Tazi A, Bergeron A. Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation. Clinical Medicine. Case Reports. 2: 11-5. PMID 24179366 DOI: 10.4137/CCRep.S2084  0.213
2008 Rea D, Bergeron A, Fieschi C, Bengoufa D, Oksenhendler E, Dombret H. Dasatinib-induced lupus. Lancet (London, England). 372: 713-4. PMID 18761212 DOI: 10.1016/S0140-6736(08)61295-7  0.212
2012 Bergeron A, Porcher R, Raffoux E, Sulahian A, Ribaud P. Response assessment in invasive aspergillosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 475-6; author reply . PMID 22563023 DOI: 10.1093/Cid/Cis415  0.198
2008 Bergeron A, Feuillet S, Meignin V, Socie G, Tazi A. Rev Mal Respir, 25 (2008), 173 Revue Des Maladies Respiratoires. 25: 262. DOI: 10.1016/S0761-8425(08)71532-8  0.187
2022 Vallet N, Le Grand S, Bondeelle L, Hoareau B, Corneau A, Bouteiller D, Tournier S, Lew-Derivry L, Bohineust A, Tourret M, Gibert D, Mayeur E, Itzykson RA, Pacchiardi K, Ingram B, ... ... Bergeron A, et al. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation. Blood. PMID 35984904 DOI: 10.1182/blood.2022016926  0.186
2021 Houist AL, Bondeelle L, Salmona M, LeGoff J, de Latour RP, Rivière F, Soler C, Houdouin V, Dalle JH, Robin C, Fourati S, Griscelli F, Coman T, Chevret S, Bergeron A. Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients. Bone Marrow Transplantation. PMID 34548625 DOI: 10.1038/s41409-021-01462-z  0.185
2021 Salvator H, Tcherakian C, Maillard N, Milin S, Bergeron A, Bondeelle L, Meignin V, NGuyen S, Souchet L, Guenounou S, Evrard SM, Rubio MT, Robin M, Sestili S, Brissot E, et al. Pulmonary alveolar proteinosis after allogeneic hematopoietic stem cell transplantation in adults: a French SFGM-TC survey. Chest. PMID 34102143 DOI: 10.1016/j.chest.2021.05.056  0.185
2009 Bergeron A, Miranda Sd, Meignin V. Cas clinique n° 2Une histoire sans fin Revue Des Maladies Respiratoires ActualitéS. 1. DOI: 10.1016/S1877-1203(09)72456-5  0.183
2012 Schlemmer F, Chevret S, Lorillon G, Peffault De Latour R, Meignin V, Michallet M, Hermet E, Wyplosz B, Houdouin V, Marchand-Adam S, Socié G, Tazi A, Bergeron A. Pneumopathies infiltrantes diffuses après allogreffe de cellules souches hématopoïétiques Revue Des Maladies Respiratoires. 29: A21-A22. DOI: 10.1016/J.Rmr.2011.10.019  0.18
2004 Bergeron A, Tazi A, Crestani B. Pneumopathies interstitielles diffuses idiopathiques Revue Des Maladies Respiratoires. 21: 1183-1186. PMID 15767968 DOI: 10.1016/S0761-8425(04)71598-3  0.178
2013 Bergeron A. The pulmonologist's point of view on lung infiltrates in haematological malignancies. Diagnostic and Interventional Imaging. 94: 216-20. PMID 23295045 DOI: 10.1016/j.diii.2012.12.004  0.178
2016 Cornetto MA, de Margerie-Mellon C, Ribaud P, Bergeron A. Reply to « Early Lung Computed Tomography Scan after Allogenic Hematopoietic Stem Cell Transplantation ». Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27422146 DOI: 10.1016/j.bbmt.2016.07.004  0.176
2022 Chiron R, Hoefsloot W, Van Ingen J, Marchandin H, Kremer L, Morisse-Pradier H, Charriot J, Mallet JP, Herrmann JL, Caimmi D, Moreau J, Dumont Y, Godreuil S, Bergeron A, Drevait M, et al. Amikacin Liposomal Inhalation Suspension in the Treatment of Lung Infection: A French Observational Experience. Open Forum Infectious Diseases. 9: ofac465. PMID 36267258 DOI: 10.1093/ofid/ofac465  0.171
2021 Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, Cheng GS, Sheshadri A, Bergeron A, Williams KM, Todd JL, Teshima T, Cuvelier GDE, Holler E, McCurdy SR, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplantation and Cellular Therapy. PMID 34217703 DOI: 10.1016/j.jtct.2021.06.001  0.169
2023 Vallet N, Salmona M, Malet-Villemagne J, Bredel M, Bondeelle L, Tournier S, Mercier-Delarue S, Cassonnet S, Ingram B, Peffault de Latour R, Bergeron A, Socié G, Le Goff J, Lepage P, Michonneau D. Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses. Cell Host & Microbe. PMID 37463582 DOI: 10.1016/j.chom.2023.06.009  0.162
2021 Bergeron A. Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions! Bone Marrow Transplantation. PMID 34145415 DOI: 10.1038/s41409-021-01381-z  0.158
2016 Cornetto MA, Chevret S, Abbes S, de Margerie-Mellon C, Hussenet C, de Fontbrune FS, Tazi A, Ribaud P, Bergeron A. Early lung CT scan after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27189110 DOI: 10.1016/j.bbmt.2016.05.009  0.157
2020 van de Ven AAJM, Alfaro TM, Robinson A, Baumann U, Bergeron A, Burns SO, Condliffe AM, Fevang B, Gennery AR, Haerynck F, Jacob J, Jolles S, Malphettes M, Meignin V, Milota T, et al. Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey. Frontiers in Immunology. 11: 606333. PMID 33324422 DOI: 10.3389/fimmu.2020.606333  0.153
2023 Cheng GS, Crothers K, Aliberti S, Bergeron A, Boeckh M, Chien JW, Cilloniz C, Cohen K, Dean N, Dela Cruz CS, Dickson RP, Greninger AL, Hage CA, Hohl TM, Holland SM, et al. Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society. 20: 341-353. PMID 36856712 DOI: 10.1513/AnnalsATS.202212-1019ST  0.153
2021 Messe R, Soccal PM, Bergeron A. [Diagnostic approach to pulmonary complications in patients with hematologic malignancy]. Revue Medicale Suisse. 17: 1984-1990. PMID 34787973  0.152
2023 Dellière S, Amar Y, Hamane S, Aissaoui N, Denis B, Bergeron A, Tazi A, Alanio A. Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia. Medical Mycology. PMID 37996394 DOI: 10.1093/mmy/myad120  0.15
2009 Borie R, Wislez M, Thabut G, Antoine M, Rabbat A, Couderc LJ, Monnet I, Nunes H, Blanc FX, Mal H, Bergeron A, Dusser D, Israël-Biet D, Crestani B, Cadranel J. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. The European Respiratory Journal. 34: 1408-16. PMID 19541720 DOI: 10.1183/09031936.00039309  0.148
2022 Marando M, Rayroux C, Bergeron A. [Alpha-1 antitrypsin deficiency]. Revue Medicale Suisse. 18: 2169-2174. PMID 36382978 DOI: 10.53738/REVMED.2022.18.804.2169  0.148
2022 Le Pavec J, Pison C, Hirschi S, Bunel V, Mordant P, Brugière O, Guen ML, Olland A, Coiffard B, Renaud-Picard B, Tissot A, Brioude G, Borie R, Crestani B, Deslée G, ... ... Bergeron A, et al. 2022 Update of indications and contraindications for lung transplantation in France. Respiratory Medicine and Research. 83: 100981. PMID 36565563 DOI: 10.1016/j.resmer.2022.100981  0.147
2021 Rousselot P, Mollica L, Guilhot J, Guerci A, Nicolini FE, Etienne G, Legros L, Charbonnier A, Coiteux V, Dartigeas C, Escoffre-Barbe M, Roy L, Cony-Makhoul P, Dubruille V, Gardembas M, ... ... Bergeron A, et al. Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients. British Journal of Haematology. PMID 34195988 DOI: 10.1111/bjh.17654  0.142
2022 Bergeron A, Mikulska M, De Greef J, Bondeelle L, Franquet T, Herrmann JL, Lange C, Spriet I, Akova M, Donnelly JP, Maertens J, Maschmeyer G, Rovira M, Goletti D, de la Camara R. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. The Lancet. Infectious Diseases. PMID 35636446 DOI: 10.1016/S1473-3099(22)00227-4  0.141
2021 Thoré P, Jaïs X, Savale L, Dorfmuller P, Boucly A, Devilder M, Meyrignac O, Pichon J, Mankikian J, Riou M, Boiffard E, Boissin C, De Groote P, Chabanne C, Gagnadoux F, ... Bergeron A, et al. Pulmonary Hypertension in Patients with Common Variable Immunodeficiency. Journal of Clinical Immunology. PMID 34110542 DOI: 10.1007/s10875-021-01064-w  0.139
2023 Mabo A, Borie R, Wemeau-Stervinou L, Uzunhan Y, Gomez E, Prevot G, Reynaud-Gaubert M, Traclet J, Bergot E, Cadranel J, Marchand-Adam S, Bergeron A, Blanchard E, Bondue B, Bonniaud P, et al. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort. Thorax. PMID 37758458 DOI: 10.1136/thorax-2023-220040  0.139
2023 Casutt A, Lamoth F, Lortholary O, Prior JO, Tonglet A, Manuel O, Bergeron A, Beigelman-Aubry C. Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians. European Respiratory Review : An Official Journal of the European Respiratory Society. 32. PMID 37758271 DOI: 10.1183/16000617.0086-2023  0.138
2023 Sidali S, Borie R, de Fontbrune FS, El Husseini K, Rautou PE, Lainey E, Goria O, Crestani B, Cadrane J, Cottin V, Bune V, Dumortier J, Jacquemin E, Reboux N, Hirschi S, ... ... Bergeron A, et al. Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors. Hepatology (Baltimore, Md.). PMID 37934624 DOI: 10.1097/HEP.0000000000000667  0.136
2008 Herrmann J, Bergeron A. Le dépistage d’une tuberculose infection latente avant la mise en route d’un traitement par anti-TNFα : critique des méthodes Revue Du Rhumatisme. 75: 194-197. DOI: 10.1016/J.RHUM.2007.09.006  0.132
2021 Michallet M, Sobh M, Morisset S, Deloire A, Raffoux E, de Botton S, Caillot D, Chantepie S, Girault S, Berthon C, Bertoli S, Lepretre S, Leguay T, Castaigne S, Marolleau JP, ... ... Bergeron A, et al. Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group. Clinical Lymphoma, Myeloma & Leukemia. PMID 34895843 DOI: 10.1016/j.clml.2021.10.011  0.132
2021 Hurst JR, Abbas SH, Bintalib HM, Alfaro TM, Baumann U, Burns SO, Condliffe A, Davidsen JR, Fevang B, Gennery AR, Haerynck F, Jacob J, Jolles S, Lamers O, Bergeron A, et al. Granulomatous-lymphocytic interstitial lung disease: an international research prioritisation. Erj Open Research. 7. PMID 34881327 DOI: 10.1183/23120541.00467-2021  0.131
2023 Bondeelle L, Vercellino L, Dres M, Bachasson D, Demoule A, Morélot-Panzini C, Similowski T, Bergeron A. F-FDG uptake by respiratory muscles in acute respiratory insufficiency in a patient with graft versus host disease. Respiratory Medicine and Research. 84: 101023. PMID 37625372 DOI: 10.1016/j.resmer.2023.101023  0.131
2023 Guerreiro I, Pautex S, Bergeron A, Baptista Peixoto Befecadu F, Hentsch L. [Early palliative care for the management of breathlessness in pulmonary diseases]. Revue Medicale Suisse. 19: 2390-2394. PMID 38117107 DOI: 10.53738/REVMED.2023.19.855.2390  0.131
2021 Boussier J, Yatim N, Marchal A, Hadjadj J, Charbit B, El Sissy C, Carlier N, Pène F, Mouthon L, Tharaux PL, Bergeron A, Smadja DM, Rieux-Laucat F, Duffy D, Kernéis S, et al. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. The Journal of Allergy and Clinical Immunology. PMID 34800432 DOI: 10.1016/j.jaci.2021.11.004  0.129
2024 Otth M, Kasteler R, Mulder RL, Agrusa J, Armenian SH, Barnea D, Bergeron A, Bhatt NS, Bourke SJ, Constine LS, Goutaki M, Green DM, Hennewig U, Houdouin V, Hudson MM, et al. Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Eclinicalmedicine. 69: 102487. PMID 38420219 DOI: 10.1016/j.eclinm.2024.102487  0.129
2010 Feuillet S, Louis L, Bergeron A, Berezne A, Dubreuil ML, Polivka M, Oksenhendler E, Tazi A. Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma. European Respiratory Review : An Official Journal of the European Respiratory Society. 19: 86-8. PMID 20956172 DOI: 10.1183/09059180.00007509  0.128
2002 Bergeron A, Laissy JP, Loiseau P, Schouman-Claeys E, Hance AJ, Tazi A. Computed tomography of pulmonary sarcoid-like granulomas induced by complete Freund's adjuvant in rats. The European Respiratory Journal. 18: 357-61. PMID 11529296 DOI: 10.1183/09031936.01.00086001  0.128
2021 Bondeelle L, Chevret S, Cassonnet S, Harel S, Denis B, de Castro N, Bergeron A. Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital: A clustering approach. Plos One. 16: e0250569. PMID 34010331 DOI: 10.1371/journal.pone.0250569  0.122
2014 Barker AF, Bergeron A, Rom WN, Hertz MI. Obliterative bronchiolitis. The New England Journal of Medicine. 370: 1820-8. PMID 24806161 DOI: 10.1056/NEJMra1204664  0.122
2024 Bondeelle L, Salmona M, Houdouin V, Diaz E, Dutrieux J, Mercier-Delarue S, Constant S, Huang S, Bergeron A, LeGoff J. Inefficient antiviral response in reconstituted small-airway epithelium from chronic obstructive pulmonary disease patients following human parainfluenza virus type 3 infection. Virology Journal. 21: 78. PMID 38566231 DOI: 10.1186/s12985-024-02353-7  0.12
2024 Houdouin V, Dubus JC, Crepon SG, Rialland F, Bruno B, Jubert C, Reix P, Pasquet M, Paillard C, Adjaoud D, Schweitzer C, Le Bourgeois M, Pages J, Yacoubi A, Dalle JH, ... Bergeron A, et al. Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter study. Bone Marrow Transplantation. PMID 38454132 DOI: 10.1038/s41409-024-02258-7  0.12
2024 Godet C, Brun AL, Couturaud F, Laurent F, Frat JP, Marchand-Adam S, Gagnadoux F, Blanchard E, Taillé C, Philippe B, Hirschi S, Andréjak C, Bourdin A, Chenivesse C, Dominique S, ... ... Bergeron A, et al. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma. Chest. PMID 38387646 DOI: 10.1016/j.chest.2024.02.026  0.12
2022 Ghrieb Z, Salmona M, Michonneau D, De Saisset C, Allaoua S, Kiladjian JJ, Le Goff J, Bergeron A, Benajiba L. Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses' infections. Therapie. PMID 36030128 DOI: 10.1016/j.therap.2022.07.010  0.113
2021 Alanio A, Gits-Muselli M, Guigue N, Denis B, Bergeron A, Touratier S, Hamane S, Bretagne S. Prospective comparison of (1,3)-beta-D-glucan detection using colorimetric and turbidimetric assays for diagnosing invasive fungal disease. Medical Mycology. PMID 33877326 DOI: 10.1093/mmy/myab016  0.11
2021 Vallet N, Chevret S, Feghoul L, Aguinaga L, Bondeelle L, Kaphan E, Bertinchamp R, Soret J, Villesuzanne C, De Castro N, Sebert M, Boutboul D, Lengline E, Tudesq JJ, Rabian F, ... ... Bergeron A, et al. Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital. Blood Cancer Journal. 11: 129. PMID 34262018 DOI: 10.1038/s41408-021-00512-5  0.109
2020 Milan T, Celton M, Lagacé K, Roques É, Safa-Tahar-Henni S, Bresson E, Bergeron A, Hebert J, Meshinchi S, Cellot S, Barabé F, Wilhelm BT. Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis. Haematologica. PMID 33375773 DOI: 10.3324/haematol.2020.271619  0.108
2023 Schlemmer F, Valentin S, Boyer L, Guillaumot A, Chabot F, Dupin C, Le Guen P, Lorillon G, Bergeron A, Basille D, Delomez J, Andrejak C, Bonnefoy V, Goussault H, Assié JB, et al. Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study. The European Respiratory Journal. PMID 36669777 DOI: 10.1183/13993003.01532-2022  0.094
2020 Seidel D, Cornely O, Zarrouk M, Koehler P, Meis JF, Salmanton-García J, Vehreschild JJ, Christner M, Gräfe SK, Falces-Romero I, Lagrou K, Maertens J, Reséndiz- Sharpe A, Racil Z, Weinbergerová B, ... ... Bergeron A, et al. 1598. Clinical implications of azole-resistant vs. azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) – a multicenter study Open Forum Infectious Diseases. 7: S795-S796. DOI: 10.1093/ofid/ofaa439.1778  0.075
2021 Biard L, Bergeron A, Lévy V, Chevret S. Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials. Contemporary Clinical Trials Communications. 21: 100709. PMID 33511301 DOI: 10.1016/j.conctc.2021.100709  0.072
2003 Bergeron A, Soler P, Kambouchner M, Loiseau P, Milleron B, Valeyre D, Hance AJ, Tazi A. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10. The European Respiratory Journal. 22: 69-76. PMID 12882453 DOI: 10.1183/09031936.03.00014703  0.065
2021 Schlemmer F, Murris-Espin M, Douvry B, Bergeron A, Burgel PR, Andrejak C, Maitre B. Management of early infection with Pseudomonas aeruginosa in adults with bronchiectasis: A survey of French pulmonologist's practices. Respiratory Medicine and Research. 80: 100859. PMID 34563790 DOI: 10.1016/j.resmer.2021.100859  0.062
2021 Godet C, Couturaud F, Marchand-Adam S, Pison C, Gagnadoux F, Blanchard E, Taillé C, Philippe B, Hirschi S, Andréjak C, Bourdin A, Chenivesse C, Dominique S, Bassinet L, Murris-Espin M, ... ... Bergeron A, et al. Nebulised liposomal-amphotericin-B as maintenance therapy in ABPA: a randomised, multicentre, trial. The European Respiratory Journal. PMID 34764182 DOI: 10.1183/13993003.02218-2021  0.059
1993 Butler MJ, Bergeron A, Soostmeyer G, Zimny T, Malek LT. Cloning and characterisation of an aminopeptidase P-encoding gene from Streptomyces lividans. Gene. 123: 115-9. PMID 8422994 DOI: 10.1016/0378-1119(93)90549-I  0.057
2011 Belcaid M, Bergeron A, Poisson G. The evolution of the tape measure protein: units, duplications and losses. Bmc Bioinformatics. 12: S10. PMID 22151602 DOI: 10.1186/1471-2105-12-S9-S10  0.057
1996 Tazi A, Bonay M, Bergeron A, Grandsaigne M, Hance AJ, Soler P. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax. 51: 611-4. PMID 8693443 DOI: 10.1136/thx.51.6.611  0.056
2021 Ghrieb Z, Allaoua S, Huang J, Langner N, François F, Maréchal C, Jebali M, Lebbé C, Chellah A, Bergeron A, Kiladjian JJ, Daltro De Oliveira R, Soret-Dulphy J, Benajiba L. [An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown]. Therapie. PMID 33640116 DOI: 10.1016/j.therap.2021.02.003  0.056
2008 Herrmann JL, Simonney N, Bergeron A, Ducreux-Adolphe N, Porcher R, Rouveau M, Allez M, Leportier M, Tazi A, Lemann M, Lagrange PH. IFNgamma and antibody responses among French nurses during a tuberculosis contact tracing investigation. Pathologie-Biologie. 57: e49-53. PMID 18395363 DOI: 10.1016/j.patbio.2008.02.010  0.051
2016 Blanquart S, Varré JS, Guertin P, Perrin A, Bergeron A, Swenson KM. Assisted transcriptome reconstruction and splicing orthology. Bmc Genomics. 17: 786. PMID 28185551 DOI: 10.1186/s12864-016-3103-6  0.05
2002 Bergeron A, Bergot E, Vilela G, Ades L, Devergie A, Espérou H, Socié G, Calvo F, Gluckman E, Ribaud P, Rousselot P, Tazi A. Hypersensitivity pneumonitis related to imatinib mesylate. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 4271-2. PMID 12377975 DOI: 10.1200/JCO.2002.99.179  0.048
2005 Caruso ME, Jenna S, Beaulne S, Lee EH, Bergeron A, Chauve C, Roby P, Rual JF, Hill DE, Vidal M, Bossé R, Chevet E. Biochemical clustering of monomeric GTPases of the Ras superfamily. Molecular & Cellular Proteomics : McP. 4: 936-44. PMID 15814614 DOI: 10.1074/Mcp.M500025-Mcp200  0.044
2007 Poisson G, Chauve C, Chen X, Bergeron A. FragAnchor: a large-scale predictor of glycosylphosphatidylinositol anchors in eukaryote protein sequences by qualitative scoring. Genomics, Proteomics & Bioinformatics. 5: 121-30. PMID 17893077 DOI: 10.1016/S1672-0229(07)60022-9  0.04
2013 Swenson KM, Guertin P, Deschênes H, Bergeron A. Reconstructing the modular recombination history of Staphylococcus aureus phages. Bmc Bioinformatics. 14: S17. PMID 24564731 DOI: 10.1186/1471-2105-14-S15-S17  0.038
2003 Luc N, Risler JL, Bergeron A, Raffinot M. Gene teams: a new formalization of gene clusters for comparative genomics. Computational Biology and Chemistry. 27: 59-67. PMID 12798040  0.036
2007 Bérard S, Bergeron A, Chauve C, Paul C. Perfect sorting by reversals is not always difficult. Ieee/Acm Transactions On Computational Biology and Bioinformatics / Ieee, Acm. 4: 4-16. PMID 17277409 DOI: 10.1109/TCBB.2007.1011  0.036
2010 Bergeron A, Medvedev P, Stoye J. Rearrangement models and single-cut operations. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 17: 1213-25. PMID 20874405 DOI: 10.1089/Cmb.2010.0091  0.035
2006 Houde M, Belcaid M, Ouellet F, Danyluk J, Monroy AF, Dryanova A, Gulick P, Bergeron A, Laroche A, Links MG, MacCarthy L, Crosby WL, Sarhan F. Wheat EST resources for functional genomics of abiotic stress. Bmc Genomics. 7: 149. PMID 16772040 DOI: 10.1186/1471-2164-7-149  0.034
2008 Bergeron A, Herrmann JL. Screening for tuberculosis before TNFalpha antagonist initiation: are current methods good enough? Joint, Bone, Spine : Revue Du Rhumatisme. 75: 112-5. PMID 18178504 DOI: 10.1016/j.jbspin.2007.09.005  0.033
2023 Bergeron A, von Garnier C. [Not Available]. Revue Medicale Suisse. 19: 2135-2136. PMID 37966143 DOI: 10.53738/REVMED.2023.19.850.2135  0.03
2022 Von Garnier C, Bergeron A. [Not Available]. Revue Medicale Suisse. 18: 2131-2132. PMID 36382972 DOI: 10.53738/REVMED.2022.18.804.2131  0.03
2015 Alanio A, Garcia-Hermoso D, Mercier-Delarue S, Lanternier F, Gits-Muselli M, Menotti J, Denis B, Bergeron A, Legrand M, Lortholary O, Bretagne S, Maizel J, Chouaki T, Hunault M, JBouchara P, et al. Molecular identification of Mucorales in human tissues: Contribution of PCR electrospray-ionization mass spectrometry Clinical Microbiology and Infection. 21: 594.e1-594.e5. DOI: 10.1016/j.cmi.2015.01.017  0.03
2006 Bergeron A, Stoye J. On the similarity of sets of permutations and its applications to genome comparison. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 13: 1340-54. PMID 17037962 DOI: 10.1089/Cmb.2006.13.1340  0.03
1989 Turmel M, Boulanger J, Bergeron A. Nucleotide sequence of the chloroplast petD gene of Chlamydomonas eugametos Nucleic Acids Research. 17: 3593-3594. PMID 2726496 DOI: 10.1093/nar/17.9.3593  0.026
2010 Ouangraoua A, Bergeron A. Combinatorial structure of genome rearrangements scenarios. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 17: 1129-44. PMID 20874400 DOI: 10.1089/cmb.2010.0126  0.026
2010 Belcaid M, Bergeron A, Poisson G. Mosaic graphs and comparative genomics in phage communities. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 17: 1315-26. PMID 20874413 DOI: 10.1089/Cmb.2010.0108  0.019
2007 Bergeron A, Belcaid M, Steward GF, Poisson G. Divide and conquer: enriching environmental sequencing data. Plos One. 2: e830. PMID 17786202 DOI: 10.1371/Journal.Pone.0000830  0.019
2016 Bérard S, Chateau A, Pompidor N, Guertin P, Bergeron A, Swenson KM. Aligning the unalignable: bacteriophage whole genome alignments. Bmc Bioinformatics. 17: 30. PMID 26757899 DOI: 10.1186/s12859-015-0869-5  0.018
2020 Maurel V, Legrand M, Bourgeois E, Masse AL, Bergeron A, Binakdane F, Ntahe A, Legouge M, Vicaut E, Plaud B. Sedation with remifentanil or propofol for flexible bronchoscopy: A randomised controlled trial. European Journal of Anaesthesiology. 37: 333-334. PMID 32132410 DOI: 10.1097/EJA.0000000000001068  0.015
2006 Bergeron A, Mixtacki J, Stoye J. On sorting by translocations. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 13: 567-78. PMID 16597257 DOI: 10.1089/Cmb.2006.13.567  0.015
2011 Ouangraoua A, Bergeron A, Swenson KM. Theory and practice of ultra-perfection. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 18: 1219-30. PMID 21899427 DOI: 10.1089/cmb.2011.0086  0.01
2005 Pasek S, Bergeron A, Risler JL, Louis A, Ollivier E, Raffinot M. Identification of genomic features using microsyntenies of domains: domain teams. Genome Research. 15: 867-74. PMID 15899966 DOI: 10.1101/gr.3638405  0.01
Hide low-probability matches.